Volume 176 - Issue 10
Haemochromatosis: Red Cross Blood Service policy
Author: Margaret L Buring
Med J Aust 2002; 176 (10): 564. || doi: 10.5694/j.1326-5377.2002.tb04541.x
Published online: 20 May 2002
Published online: 20 May 2002
To the Editor: The Australian Red Cross Blood Service (ARCBS) introduced a national policy for therapeutic venesection in December 1999 which allows the collection of blood from people with haemochromatosis. There is no charge for this service.
The policy outlines the principles under which ARCBS provides a therapeutic venesection service, conditions of management of the donors and the acceptability of the donations for clinical use.1 These conditions are:
The patient's condition benefits from regular venesection and the patient does not have a transfusion-transmissible disease.
The blood donation will be used in clinical or derivative products only if the donors fully meet the donor selection guidelines for clinical use.
Responsibility for patient management remains with the referring physician.
ARCBS is responsible for the collection and for ensuring donor safety during the procedure. We will liaise with referring physicians about the venesection protocol if necessary, and reserve the right to refuse to venesect if there is a concern for donor safety.
A diagnosis of hereditary haemochromatosis (evidence of iron overload together with appropriate genetic studies2) is required before patients are accepted into the therapeutic venesection program.
Contact your local ARCBS for copies of the therapeutic request form. Completion of this will facilitate the entry of people to the ARCBS therapeutic program.
The full policy can be obtained from our website <www.arcbs.redcross.org.au>.
References
- Sanchez AM, Schreiber GB, Bethel J, et al. Prevalence, donation practices and risk assessment of blood donors with hemochromatosis. JAMA 2001; 286: 1475-1481.
- Vautier G, Murray M, Olnyk JK. Hereditary haemochromatosis: detection and management. Med J Aust 2001; 175: 418-421. i1149878
Splenic injury in severe cases of the zoonoses Q fever and rickettsial infection: diagnostic challenges
Ashleigh Drury, Philippa Harrison, Aiveen Bannan
Health and economic benefits of improving pre‐hospital identification of stroke in Australian women: a modelling study
Thomas Gadsden, Lei Si, Emily R Atkins, Cheryl Carcel, Xia Wang, Stephen Jan, Mark Woodward, Laura E Downey
Updating the diagnosis and management of elevated serum ferritin levels in the era of routine ferritin testing of blood donors by Australian Red Cross Lifeblood
Gary D Zhang, James Chen, Daniel M Johnstone, Martin B Delatycki, Katie Allen, John K Olynyk
Early cardiovascular collapse after envenoming by snakes in Australia, 2005–2020: an observational study (ASP‐31)
Geoffrey K Isbister, Katherine Z Isoardi, Angela L Chiew, Shane Jenkins, Nicholas A Buckley
Updated recommendations for warfarin reversal in the setting of four‐factor prothrombin complex concentrate
Danielle Robinson, James McFadyen, Eileen Merriman, Chee Wee Tan, Ross Baker, Huyen Tran
Updating the diagnosis and management of iron deficiency in the era of routine ferritin testing of blood donors by Australian Red Cross Lifeblood
Gary D Zhang, Daniel Johnstone, Michael F Leahy, John K Olynyk